Health-care providers’ views of menopause and its management: a qualitative study

Davis, Susan Ruth; Herbert, Dilinie; Reading, Meghan; Bell, Robin Jean

doi:10.1080/13697137.2021.1936486

Cited by 18 publications

(24 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many women with bothersome VMS remain untreated or use nonprescription medications, herbal supplements or alternative therapies [15][16][17]. Factors influencing treatment decisions include safety and tolerability (e.g., breast cancer, stroke, venous thromboembolism, breast tenderness, vaginal bleeding) related to long-term HT use [18][19][20][21][22] and moderate efficacy of non-hormonal treatments [10]. Although previous studies have examined the burden of VMS associated with menopause [7,8], a more comprehensive understanding of VMS burden and patient/physician perspectives on its management is needed.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States

et al. 2022

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States

et al. 2022

View full text Add to dashboard Cite

“…These rates are likely to be underestimates, given that not all HCPs inquire about their use, and black cohosh was rarely initiated based on discussion with the HCP (18 [9.5%] of 190 users) 19 . In an Australian study, most HCPs (4/10 general practitioners, 7/10 GYNs, and 8/10 pharmacists) expressed concern about the limited evidence of efficacy of nonprescription therapies, and some attributed the effects of these agents to placebo effect; however, 7 of 10 Australian PCPs similarly said that complementary and alternative medicine nonetheless “have a role” and do not discourage their use 21 . Six of 10 pharmacists in that study specifically recommend such therapies to clients for managing symptoms of menopause 21 .…”

Section: Discussionmentioning

confidence: 99%

“…In an Australian study, most HCPs (4/10 general practitioners, 7/10 GYNs, and 8/10 pharmacists) expressed concern about the limited evidence of efficacy of nonprescription therapies, and some attributed the effects of these agents to placebo effect; however, 7 of 10 Australian PCPs similarly said that complementary and alternative medicine nonetheless “have a role” and do not discourage their use 21 . Six of 10 pharmacists in that study specifically recommend such therapies to clients for managing symptoms of menopause 21 . Almost half (42%) of US HCPs in the survey of the large Midwestern health maintenance organization found complementary/alternative therapies to be useful or extremely useful, and black cohosh was among the nonprescription therapies that HCPs recommended for treatment of VMS and dyspareunia 23 .…”

Section: Discussionmentioning

confidence: 99%

Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers

DePree

Houghton²,

DiBenedetti

et al. 2022

Menopause

View full text Add to dashboard Cite

Objective: To document health care providers' views regarding treatments for symptoms associated with menopause and discussions with patients about symptoms and treatment decisions. Results informed development of a data collection form for a retrospective medical record review (reported separately).Methods: Registered US gynecologists or primary care providers from all US regions were identified from local association directories and an in-house database and were invited to participate in a qualitative interview if they consulted with three or more patients per week presenting with menopausal symptoms. Participants provided demographic data, information about patients' symptoms, and health care provider and patient views on prescription and nonprescription therapies. Key concepts/themes from interviews were identified.Results: Participating health care providers (10 gynecologists, 10 primary care providers) agreed there are effective treatment options for menopausal symptoms, particularly vasomotor symptoms and vaginal dryness and/or atrophy. Health care providers reported that treatment was generally dictated by symptoms that interfered with quality of life and/or daily activities, although patients often had symptoms for months before presentation. All health care providers said they prescribe hormone and/or nonhormone therapies for treatment of menopausal symptoms; half stated that they typically inquire about patients' nonprescription therapy use, and 45% recommend specific nonprescription therapies. The most commonly cited barriers to initiation of any therapy for menopausal symptoms were patient concerns about risks and financial considerations (ie, insurance or cost).Conclusions: US health care providers reported prescribing therapies for menopausal symptoms and noted that these therapies were perceived as generally effective; however, barriers to initiation of prescription therapy exist, and new treatment options are needed.

show abstract

“…Research by Davis et al among Australian healthcare providers showed that although they appeared to have a solid understanding of menopause and its consequences, they were uncertain of its management. The commission of menopausal hormone therapy appeared to be limited to women with severe symptoms despite lifestyle changes and attempts to use complementary and alternative medicine [ 44 ]. Menopause hormone therapy (MHT), currently available in an ever-expanding array of formulations, routes of administration, and dosages, continues to appear to be the most effective treatment for menopause-related symptoms.…”

Section: Saliva Of Menopausal Womenmentioning

confidence: 99%

Changes in the Oral Cavity in Menopausal Women—A Narrative Review

Ciesielska

Kusiak

Ossowska

et al. 2021

IJERPH

View full text Add to dashboard Cite

Oral health awareness during the menopausal period is essential to minimize the inevitable inconveniences which may occur due to hormonal changes. The decrease in estrogen hormone concentration impacts the oral mucosa in a similar way to the vaginal mucosa due to the presence of estrogen receptors in both of these structures. An estrogen deficiency also affects the maturation process of the oral mucosal epithelium and can lead to its thinning and atrophy, making it more susceptible to local mechanical injuries, causing a change in pain tolerance and problems in the use of removable prosthetic restorations. Mucosal epithelium during the menopausal period is more vulnerable to infections, candidiasis, burning mouth syndrome, oral lichen planus (OLP), or idiopathic neuropathy. Moreover, salivary glands are also hormone-dependent which leads to changes in saliva secretion and its consistency. In consequence, it may affect teeth and periodontal tissues, resulting in an increased risk of caries and periodontal disease in menopausal women. Due to the large variety of complaints and symptoms occurring in the oral cavity, menopausal women constitute a significant group of patients who should receive special preventive and therapeutic care from doctors and dentists in this particular period.

show abstract

Health-care providers’ views of menopause and its management: a qualitative study

Cited by 18 publications

References 15 publications

Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States

Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States

Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers

Changes in the Oral Cavity in Menopausal Women—A Narrative Review

Contact Info

Product

Resources

About